FD&C Act Section 503A / 503B Legal Disclaimer

1. Official FD&C Act Section 503A / 503B Disclaimer

All products listed on this website are strictly for in-vitro laboratory research and development use only. Products are not for human or animal consumption of any kind. The statements made on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.

Prime Labs is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Prime Labs is not an outsourcing facility as defined under Section 503B of the Federal Food, Drug, and Cosmetic Act.

2. No Dosing or Clinical Guidance

All lyophilized peptides are supplied exclusively for qualified analytical and laboratory investigation. Prime Labs does not provide medical advice, human reconstitution instructions, or clinical dosing protocols.